Skip to content

Ethics Advisory Board

Our Ethics Advisory Board is committed to building our company with integrity and ethical business behavior.

Since 2008, Illumina convened an Ethics Advisory Board (EAB) to ensure that Illumina acts ethically and justly in its business operations. The EAB meets quarterly to advise and provide recommendations regarding ethical issues involving Illumina’s existing, emerging, and prospective products, services, and processes both from a research and clinical perspective. This includes providing strategic advice to Illumina regarding emerging ethical issues, policies, and regulations relevant to the genomics industry.